Citius Pharmaceuticals Inc (CTXR)
0.137
-0.03
(-17.02%)
USD |
NASDAQ |
Nov 22, 10:03
Citius Pharmaceuticals Price to Book Value: 0.2889 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 0.3482 |
| November 20, 2024 | 0.3584 |
| November 19, 2024 | 0.4045 |
| November 18, 2024 | 0.4729 |
| November 15, 2024 | 0.4218 |
| November 14, 2024 | 0.6927 |
| November 13, 2024 | 0.8135 |
| November 12, 2024 | 1.017 |
| November 11, 2024 | 0.9475 |
| November 08, 2024 | 0.8679 |
| November 07, 2024 | 0.8061 |
| November 06, 2024 | 0.7319 |
| November 05, 2024 | 0.7376 |
| November 04, 2024 | 0.7361 |
| November 01, 2024 | 0.757 |
| October 31, 2024 | 0.7861 |
| October 30, 2024 | 0.8536 |
| October 29, 2024 | 0.8234 |
| October 28, 2024 | 0.7802 |
| October 25, 2024 | 0.7678 |
| October 24, 2024 | 0.7298 |
| October 23, 2024 | 0.7532 |
| October 22, 2024 | 0.7783 |
| October 21, 2024 | 0.8104 |
| October 18, 2024 | 0.8247 |
| Date | Value |
|---|---|
| October 17, 2024 | 0.8648 |
| October 16, 2024 | 0.869 |
| October 15, 2024 | 0.7891 |
| October 14, 2024 | 0.7498 |
| October 11, 2024 | 0.7745 |
| October 10, 2024 | 0.8439 |
| October 09, 2024 | 0.8272 |
| October 08, 2024 | 0.8192 |
| October 07, 2024 | 0.8331 |
| October 04, 2024 | 0.9154 |
| October 03, 2024 | 0.9399 |
| October 02, 2024 | 0.9903 |
| October 01, 2024 | 0.9873 |
| September 30, 2024 | 1.056 |
| September 27, 2024 | 1.101 |
| September 26, 2024 | 1.090 |
| September 25, 2024 | 1.089 |
| September 24, 2024 | 1.139 |
| September 23, 2024 | 1.162 |
| September 20, 2024 | 1.202 |
| September 19, 2024 | 1.156 |
| September 18, 2024 | 1.076 |
| September 17, 2024 | 1.057 |
| September 16, 2024 | 1.065 |
| September 13, 2024 | 1.097 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2889
Minimum
Nov 22 2024
11.68
Maximum
Feb 23 2021
1.884
Average
1.670
Median
Jul 19 2024
Price to Book Value Benchmarks
| Citius Oncology Inc | -- |
| Agilent Technologies Inc | 6.425 |
| Merck & Co Inc | 5.750 |
| Cara Therapeutics Inc | 22.50 |
| Moleculin Biotech Inc | 1.136 |
Price to Book Value Related Metrics
| Price | 0.137 |
| Earnings Yield | -175.2% |
| Market Cap | 24.76M |